Skip to content

D&A at other companies

Danaher logo
DanaherDHR
$193M+6.6%
Revvity logo
RevvityRVTY
$105.06M+7.8%
Quest Diagnostics logo
Quest DiagnosticsDGX
$147M+5.0%
Opko Health logo
Opko HealthOPK
$22.2M-5.5%
Agilent Technologies logo
Agilent TechnologiesA
$67M-8.2%
Labcorp Holdings logo
Labcorp HoldingsLH
$173.3M+3.9%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's D&A?
QuidelOrtho Corporation (QDEL) reported D&A of $112.9M in Q1 2026.
How has QuidelOrtho Corporation's D&A changed year-over-year?
QuidelOrtho Corporation's D&A increased by 5.4% year-over-year, from $107.1M to $112.9M.
What is the long-term trend for QuidelOrtho Corporation's D&A?
Over 4 years (2021 to 2025), QuidelOrtho Corporation's D&A has grown at a 70.2% compound annual growth rate (CAGR), from $52.7M to $442M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.